Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “Relapsing-remitting multiple sclerosis”
Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02090413. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects
ClinicalTrials.gov study NCT00292253. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany
ClinicalTrials.gov study NCT02125604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04767698. IPD Sharing: NO. Countries: 1. Publications: 0.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]
ClinicalTrials.gov study NCT01134627. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atorvastatin in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00616187. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT00882999. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants
ClinicalTrials.gov study NCT03870763. IPD Sharing: YES. Countries: 13. Publications: 0.
Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04178980. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif
ClinicalTrials.gov study NCT00317941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01093326. IPD Sharing: Not stated. Countries: 20. Publications: 0.
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
ClinicalTrials.gov study NCT01436643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Disease modifying therapy reduces the risk of disability in relapsing-remitting multiple sclerosis over 15 years
Open the record for dataset details and reuse information.
Defective structural RNA processing in relapsing-remitting multiple sclerosis
GEO Series GSE66573. Homo sapiens. 14 samples. Type: Expression profiling by high throughput sequencing.
Disease modifying therapy impacts on miRNA expression profiling in peripheral blood from Relapsing-Remitting Multiple Sclerosis patients
GEO Series GSE230064. Homo sapiens. 65 samples. Type: Non-coding RNA profiling by array.
Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07346924. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
ClinicalTrials.gov study NCT01167426. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00917839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01310166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00200655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.